Lidds AB | |
Stock Exchange | First North Sweden |
EPS |
SEK0.35 |
Market Cap |
SEK414.46 M |
Shares Outstanding |
21.87 M |
Public Float |
- |
Address |
Virdings Allé 32B Uppsala UP 754 50 Sweden |
Employees | - |
Website | http://www.lidds.se |
Updated | 09/14/2018 |
LIDDS AB operates as a pharmaceutical company. It engages in the research and development of pharmaceutical products. The company focuses on the development of treatment alternatives and hormonal therapy for prostate cancer. |